Free Trial
OTCMKTS:RGEDF

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. (RGEDF) Stock Price, News & Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. logo
$27.17 0.00 (0.00%)
As of 01/29/2025

About Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Stock (OTCMKTS:RGEDF)

Key Stats

Today's Range
$27.17
$27.17
50-Day Range
$27.17
$27.17
52-Week Range
$21.47
$29.58
Volume
N/A
Average Volume
389 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. It operates through two segments, Pharmaceuticals, and Wholesale and Retail. The company offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital solutions to enhance women's lives. It also provides central nervous system products, such as products for the treatment of chronic cerebral circulatory disorders and neuropathic pain; and aesthetics, anti-anxiety medications, sleeping pills, and anti-epileptic medicines, as well as products for the prevention and treatment of various cardiovascular diseases. In addition, the company produces various over-the-counter products for various health problems comprising Panangin for heart support; Escapelle and Postinor, an emergency contraceptive pill; Stopdiar and Nifuroxazide to treat diarrhea; RICHTER CycleBalance for infertility and PCOS; Curiosin for wound care; Groprinosin for antiviral and immunostimulant; Folik, a pregnancy supplement; Moilec for back and joint pain; Fasconal, a pain relief tablet; Lordestin for allergy; Magnezin, a magnesium supplement; Aflamil, an anti-inflammatory and antirheumatic cream; Oralsept, a sore throat and local anesthetic. Further, it provides financial and accounting, social and welfare, portfolio and project management, catering, carriage transportation, engineering, quality control, trading, asset management, and biotechnological services. Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. was founded in 1901 and is headquartered in Budapest, Hungary.

Receive RGEDF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. and its competitors with MarketBeat's FREE daily newsletter.

RGEDF Stock News Headlines

Better than Bitcoin – and potentially more profitable
The world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin Skimming allows you to “skim” cash into your account thanks to 2025’s surging Bitcoin market.
Erich Richter
Chemical Works of Gedeon Richter PLC DR
Chemical Works of Gedeon Richter PLC
See More Headlines

RGEDF Stock Analysis - Frequently Asked Questions

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.'s stock was trading at $27.1736 at the start of the year. Since then, RGEDF shares have increased by 0.0% and is now trading at $27.1736.
View the best growth stocks for 2025 here
.

Shares of RGEDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
1/30/2025
Next Earnings (Estimated)
2/26/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:RGEDF
CIK
N/A
Fax
N/A
Employees
11,603
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (OTCMKTS:RGEDF) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners